SCHEMBL9934057

SCHEMBL9934057

CC(C)NC(C)C.N#CCCSPSCCC#N

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.33
TSHR P16473 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25968298 0.71
SCHEMBL8328895 0.71 TDP1 (0.38) TDP1TSHR
SCHEMBL27864231 0.70 TSHR (0.50) TDP1TSHR
SCHEMBL2455808 0.69 TDP1 (0.40) TDP1TSHR
SCHEMBL10530966 0.68 TDP1 (0.35) TDP1TSHR
SCHEMBL992741 0.67 TDP1 (0.33) TDP1TSHR
SCHEMBL24767740 0.64
SCHEMBL27280583 0.64 TSHR (0.48) TDP1TSHR
SCHEMBL27287322 0.64 TSHR (0.48) TDP1TSHR
SCHEMBL27280584 0.64 TSHR (0.48) TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10131908-B2 5′ phosphate mimics ALNYLAM PHARMACEUTICALS, INC. (US) 2018-11-20 US disclosed
US-20150080457-A1 5' PHOSPHATE MIMICS BANK OF AMERICA, N.A. 2015-03-19 US disclosed
US-8927513-B2 5′ phosphate mimics ALNYLAM PHARMACEUTICALS, INC. (US) 2015-01-06 US disclosed
US-20120157511-A1 5' PHOSPHATE MIMICS ALNYLAM PHARMACEUTICALS, INC. (US) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157511-A1 5' PHOSPHATE MIMICS NSUN2, RNGTT, RNMT TDP1 514/4885TSHR 3336/4885
US-20150080457-A1 5' PHOSPHATE MIMICS NSUN2, RNGTT, RNMT TDP1 518/4885TSHR 3344/4885
US-10131908-B2 5′ phosphate mimics NSUN2, RNGTT, RNMT TDP1 515/4885TSHR 3339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.